Radial Shockwave Versus Low Level Laser Therapy in Patients With Chronic Piriformis Muscle Syndrome
Launched by CAIRO UNIVERSITY · Jan 1, 2025
Trial Information
Current as of July 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of two different treatments for people with chronic piriformis syndrome, which is a condition that can cause pain in the lower back, buttocks, and legs due to irritation of the piriformis muscle. The trial will compare radial shockwave therapy and low-level laser therapy to see which one works better in reducing pain, improving muscle function, and increasing hip movement.
To be eligible for this study, participants should be between 30 and 50 years old, have a body mass index (BMI) between 25 and 30, and have been experiencing pain related to piriformis syndrome, which may include discomfort radiating down the leg. Participants will be evaluated using specific tests to confirm their condition. It's important to note that this trial is not currently recruiting participants, but if you meet the criteria, you could expect to receive one of the two treatments and be monitored for changes in your symptoms and function.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Sixty patients' males and females with piriformis syndrome
- • Their age will range from 30-50 years old
- • Body mass index will be 25 to 30 (kg/m²).
- • Both males and females.
- • Low back pain radiating to posterior thigh, calf and Foot.
- • Chronic piriformis syndrome due to micro trauma.
- • Gluteal pain with or without radiation through sciatic nerve pathway.
- • Faber test and Fair test and Beatty test positive.
- • Diagnosed sub-acute and chronic piriformis syndrome.
- • One-sided piriformis syndrome.
- • Tenderness over lower back, buttocks and hip joint.
- Exclusion Criteria:
- • - Piriformis syndrome due to macro trauma.
- • Lumbo-sacral disc lesion and spinal stenosis.
- • Lumbar spondylolisthesis.
- • Pregnancy
- • Recent fracture and surgery of spine, hip, knee and Ankle.
- • Baker's cyst.
- • Degenerative disease of spine and hip.
- • Intermittent vascular claudication.
- • Past history of vertebral fracture and spinal surgery
- • Spinal tuberculosis.
- • Rheumatoid disease.
- • Disc pathology and mechanical back pain.
- • Presence of malignant disease.
About Cairo University
Cairo University, a premier institution in Egypt, is dedicated to advancing medical research and education through innovative clinical trials. With a strong emphasis on improving healthcare outcomes, the university collaborates with various stakeholders to conduct rigorous scientific studies that address critical health challenges. Leveraging its extensive resources and expert faculty, Cairo University aims to contribute valuable insights to the medical community and enhance patient care both locally and globally. Through its commitment to ethical research practices and excellence, the university plays a pivotal role in shaping the future of healthcare in the region.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Giza, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported